The primary risks are: (1) Earnings volatility—EPS has fluctuated wildly, and the trailing P/E of 94.1x leaves no room for error; any miss could cause a sharp selloff. (2) Commodity price sensitivity—revenue depends on animal by-product and used cooking oil prices, which can be volatile. (3) Regulatory risk—changes to biofuel mandates (e.g., RFS) could directly impact the Fuel Ingredients segment. (4) Valuation risk—the stock is near its 52-week high ($66.02), and failure to break above could lead to profit-taking. The most severe risk is a combination of earnings disappointment and adverse policy changes, which could drive the stock down 53% to the 52-week low of $29.15. Investors should monitor Q2 2026 results and EPA announcements closely.

The 12-month outlook is bullish with a base case (50% probability) targeting $65-$75, aligning with the analyst average of $75.42. The bull case (30% probability) sees the stock reaching $75-$85 if earnings momentum accelerates, driven by strong Fuel Ingredients demand and margin expansion. The bear case (20% probability) projects downside to $50-$62 if the recovery stalls due to commodity price declines or regulatory headwinds. The most likely scenario is the base case, where revenue grows 10-12% YoY and net margins stabilize around 8-9%. Key assumptions include sustained gross margins above 17% and no adverse biofuel policy changes. The stock's 20.7% upside to the average target suggests a favorable risk/reward, but investors should watch Q2 2026 earnings for confirmation.

On a trailing basis, DAR appears overvalued with a P/E of 94.1x, near the top of its 5-year historical range of 10x-120x. However, this is misleading because earnings are recovering from a trough. On a forward basis, the P/E of 11.9x is well below the industry median of ~18x, suggesting the stock is undervalued if earnings materialize as expected. The P/S ratio of 0.97x is also below the historical average of ~5x, further supporting the value case. The market is pricing in a sharp earnings rebound, and if the company delivers, the current price offers a significant margin of safety. The wide gap between trailing and forward P/E indicates that the market expects a dramatic improvement in profitability, which is already underway.

Darling Ingredients offers a compelling risk/reward for investors with a medium-to-high risk tolerance. The stock has strong analyst support (Strong Buy consensus, 20.7% upside to the average target of $75.42) and is trading at a forward P/E of 11.9x, a 34% discount to the Packaged Foods industry median of ~18x. However, the trailing P/E of 94.1x reflects high expectations, and earnings have been volatile (EPS swung from -$0.16 to $0.85 in the past year). The biggest downside risk is a failure to sustain earnings momentum, which could trigger multiple compression. For investors who believe the turnaround is durable, DAR is a good buy at current levels, but it requires conviction and patience. Conservative investors may prefer to wait for a pullback to the $55-$58 range or confirmation of Q2 2026 results.

DAR is better suited for long-term investment (12+ months) given its cyclical nature and earnings recovery phase. The stock has a beta of 1.04, indicating market-like volatility, and its 77.6% one-year gain suggests short-term momentum could be exhausted. The company does not pay a dividend (payout ratio 0%), so total return depends on price appreciation. For long-term investors, the forward P/E of 11.9x and strong free cash flow ($551M TTM) provide a margin of safety if the turnaround continues. Short-term traders may find opportunities around earnings announcements or technical breakouts above $66.02, but the stock's volatility (max drawdown -24.61%) requires careful risk management. A minimum holding period of 12 months is recommended to allow the earnings recovery to fully materialize.